Of particular note for post

Of particular note for post
Welcome to a Biomedical Battery specialist of the Nihon Kohden Battery
The Indian Defibrillator Market is witnessing steady growth primarily as a result of rising incidence of cardiovascular diseases and disorders. Additionally, widespread availability of modern medical facilities as well as GOI initiatives for expanding trauma services centers to create awareness among people will further fuel growth of the Indian defibrillator market over the coming Quarters.
According to this report, India Defibrillator Market shipments reached $2.7 million in CY Q1 2014. PHILIPS HEALTHCARE led the market followed by ST. JUDE MEDICAL and ZOLL MEDICAL CORPORATION. The Implantable Cardioverter Defibrillators (ICDs) segment with less than 80 with battery such as Nihon Kohden TEC-5521 Battery, Nihon Kohden TEC-5531 Battery, Nihon Kohden TEC-7431 Battery, Nihon Kohden TEC-7500 Battery, Nihon Kohden TEC-7521 Battery, Nihon Kohden TEC-7531 Battery, Nihon Kohden TEC-7600 Battery, Nihon Kohden TEC-7621 Battery, Nihon Kohden TEC-7700 Battery, Nihon Kohden TEC-7721 Battery, Nihon Kohden TEC-8321 Battery, Nihon Kohden TEC-8342 Battery, Nihon Kohden NKB-301V Battery, Nihon Kohden YS-076P5 Batterygrams weight dominated the India Defibrillator Market with 78% share.
.S.-market leader in medical instrumentation solutions, will showcase its novel BSM-1700 transport monitor at the Anesthesia Society of America’s ANESTHESIA 2015 meeting, held Oct. 24-28 in San Diego, Calif. Developed to address the heightened safety challenges of transporting at-risk patients between points of care in the hospital setting, the lightweight monitor is the only one of its kind to capture the most comprehensive set of physiologic parameters needed during transit in a standard configuration, making it uniquely capable of safeguarding patients at one of the most critical points in the care continuum.
Studies have shown an increased risk to patient safety during intrahospital transport, especially among critically ill patients. According to the guidelines established by the American College of Critical Care Medicine, careful planning, qualified staff and use of the right equipment are key to managing this risk.1 Nihon Kohden’s BSM-1700 is the only commercially available transport monitor that tracks key parameters, such as electrocardiography, respiration, blood oxygen, non-invasive and invasive blood pressure, temperature, cardiac output, bispectral index, as well as carbon dioxide (CO2) in it base configuration. Of particular note for post-anesthesia patients is the monitor’s ability to track end-tidal CO2, a critical measure of ventilation status, during transit from the operating room to the post-anesthesia care unit or critical care unit.
“When it comes to patient safety, there is no room for compromise at Nihon Kohden,” said Dr. Wilson P. Constantine, chief executive officer, Nihon Kohden America. “The robust profile of our base BSM-1700 transport monitor represents our steadfast commitment to delivering the right technology when and where it is needed, no matter what.”
The BSM-1700 is designed to work as a transport monitor, stand-alone monitor or input unit for Nihon Kohden’s BSM-6000 or BSM-9000 bedside monitors. With five hours of standard battery life and no additional peripheral devices or cables required, it gives healthcare providers a flexible, easy-to-use solution that ensures seamless transfer of data from admission to discharge and one standard of care throughout the patient stay.